VR Logo

Better Therapeutics Inc. (BTTX) download report


Healthcare | Biotechnology & Pharma Research

Better Therapeutics Inc. (BTTX) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States.

IPO Date: 28-Oct-2021

Co-Founder & Exec. Chairman: Mr. David P. Perry M.B.A.

Co-Founder, CEO & Director: Mr. Kevin J. Appelbaum

Listing: NASDAQ: BTTX

Country: United States

Headquarters: San Francisco, CA

Website: https://www.bettertx.com

Key Facts

Market cap: $44.15 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-45.46 Mln

Cash: $31.67 Mln

Total Debt: $9.60 Mln

Insider's Holding: 59.25%

Liquidity: Low

52 Week range: $0.91 - 29.40

Shares outstanding: 23,609,900

Stock Performance

Time Period Better Therapeutics (BTTX) S&P BSE Sensex S&P Small-Cap 600
YTD-62.37-8.74-17.05
1 month-22.91-2.01-4.75
3 months-22.22-7.32-12.65
1 Year-82.380.45-16.28
3 Years--10.328.01
5 Years--11.296.35
10 Years--12.1410.55
As on 27-Jun-2022